Asensus Surgical

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Asensus Surgical reports Q1 loss but eyes stability through acquisition

Asensus Surgical's Q1 2024 performance showed a significant net loss, but the potential acquisition by KARL STORZ offers financial stability. The company aims to sustain operations into Q3 2024 and beyond with available cash and additional financing. Ongoing initiatives focus on advancing surgical systems and expanding global programs.

Asensus Surgical reports Q2 losses, merger vote adjourned

Asensus Surgical faces financial struggles with a significant net loss and liquidity concerns.
The proposed merger with Karl Storz offers a potential strategic advantage but hinges on stockholder approval.
Addressing operational inefficiencies and investor engagement are critical for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Asensus Surgical is a digital interface between the surgeon and patient to improve minimally invasive surgery through digital laparoscopy. They enable capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seek to address the current clinical, cognitive, and economic shortcomings in surgery.

Asensus Surgical Inc (NYSE: ASXC) has filed a 510(k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit (ISU).  The ISU is used on the Company's Senhance Surgical System, which enables digital laparoscopy.

Asensus Surgical Files For FDA Nod For Additional Capabilities Of Laparoscopy System

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has filed a 510(k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™). The ISU is utilized on the Company's Senhance Surgical System which enables digital laparoscopy. “The

Asensus Surgical Announces 510(k) Submission to FDA for Machine Vision Capabilities Expansion

Adomani

AIM ImmunoTech Inc

Cinedigm

Galectin Therapeutics

Genius Brands

Luokung Technology Corp

Electrameccanica

Are these 'must watch' penny stocks on your radar? The post 8 ‘Must Watch' Penny Stocks For Your July 2021 List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

8 ‘Must Watch' Penny Stocks For Your July 2021 List

ASXC stock's growth potential is tied to preferences for costly robotic surgery and the ability of the Senhance System to reduce those costs. The post Asensus Is a Bet on the Push to Reduce Robotic Surgery Costs appeared first on InvestorPlace.

Asensus Is a Bet on the Push to Reduce Robotic Surgery Costs

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference. The virtual presentation is sched

Asensus Surgical to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company's 2021 Annual Meeting of Stockholders, scheduled to be held on Tuesday, June 29, 2021 at 11:00 a.m. (Eastern Time), was again adjourned to Thursday, July 22, 2021 at 1:00 p.m. (Eastern Time). The Annual Meeting will be held virtua

Asensus Surgical 2021 Annual Meeting of Stockholders Is Adjourned to July 22, 2021

Senmiao Technology

BEST Inc - ADR

CYREN

iQSTEL Inc.

Iterum Therapeutics Plc

Rigel Pharmaceuticals

Looking for penny stocks to buy in July 2021? Here's 7 for your watchlist The post Top Penny Stocks to Buy in July?

Top Penny Stocks to Buy in July? 7 You May Not Know About

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced Inselspital, University Hospital Bern, Switzerland has initiated its Senhance® Surgical System program. This is the second of two new agreements with two hospitals in Europe thus far in 2021, as previously announced in our May 11, 2021 news releas

Asensus Surgical Announces Inselspital University Hospital in Bern, Switzerland to start Senhance Surgery

Ebang International Holdings

GTT Communications

Inuvo

Micronet Enertec Technologies

Senseonics Holdings

Synchronoss

Why are tech penny stocks so popular in 2021? Here's your answer and 7 to watch right now The post Tech Penny Stocks Are in Focus, Here's Why And 7 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Tech Penny Stocks Are in Focus, Here's Why And 7 to Watch

Resonant

Zomedica

Diversify your portfolio with 7 high-return penny stocks that could be the next big thing based on facts instead of fantasy. The post 7 Penny Stocks That Could Be the Next Big Thing appeared first on InvestorPlace.

7 Penny Stocks That Could Be the Next Big Thing

For those looking for short-term trades, this could still end up being a profitable opportunity. But, considering its history of disappointments, don't be surprised if sentiment for ASXC stock once again turns on a dime.

If You're Buying The Asensus Surgical Stock Rebound, Watch Out

Atossa Genetics

Citius Pharmaceuticals

GT Biopharma Inc

If biotech penny stocks are your focus, check these 4 out right now The post 4 Top Biotech Penny Stocks To Watch In The Second Half Of June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Top Biotech Penny Stocks To Watch In The Second Half Of June 2021

Lion Group Holding

Are these the best penny stocks to watch in June 2021? The post 4 Penny Stocks to Watch That Are Pushing Up in June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks to Watch That Are Pushing Up in June 2021

As Asensus pioneers a new standard of digitally enhanced surgery, ASXC stock holders should stay patient and hold on for the long term. The post Asensus Surgical Stock Is Coiling for the Next Move Higher appeared first on InvestorPlace.

Asensus Surgical Stock Is Coiling for the Next Move Higher

American Resources Corp

Uxin Ltd - ADR

Penny stocks on Reddit are seeing increased momentum; which small-caps are you watching? The post Reddit Penny Stocks to Watch in 2021?

Reddit Penny Stocks to Watch in 2021? Here's 4 For Your List

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the company will be added to the Russell 2000® and Russell Microcap® Indexes at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions

Asensus Surgical to Join the Russell 2000® and Russell Microcap® Indexes

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company's 2021 Annual Meeting of Stockholders, scheduled to be held on Thursday, June 3, 2021 at 3:00 p.m. (Eastern Time), was adjourned to Tuesday, June 29, 2021 at 11:00 a.m. (Eastern Time). The Annual Meeting will be held virtually. Th

Asensus Surgical 2021 Annual Meeting of Stockholders Is Adjourned

Asensus develops and markets an advanced digital laparoscopy system, Senhance.

Asensus Surgical: Digging In Against Incumbents In The Robotic Surgery Field

Asensus claims its Senhance can do a hysterectomy for half what Intuitive's DaVinci robot costs, with renewable instruments and haptic feedback. The long haul is the only way to play ASXC stock.

Asensus Surgical Investors Need To Take Long-Term View on Its Technology

An analyst initiated a buy recommendation for the surgical-robot company.

Why Asensus Surgical Stock Is Soaring Today

Tilray Brands

GameStop (NYSE:GME) Is Surging Bringing Validity To Countless Penny Stocks Right Now The post Are Penny Stocks Worth It? 3 Cheap Stocks To Watch Before June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are Penny Stocks Worth It? 3 Cheap Stocks To Watch Before June 2021

ASXC stock got an analyst 'buy' rating just days after reporting positive Q1 results. Asensus Surgical remains a worthy investment.

ASXC Stock: Why Popular Play Asensus Surgical Is Climbing Today

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer MedTech, Tools & Diagnostics Summit taking place May 26, 2021. The C

Asensus Surgical to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

ASXC stock holders should appreciate the company's ambitious vision as Asensus introduces its innovative surgical tech into multiple regions. The post Hold Asensus Surgical Stock as Next-Gen Senhance System Gains Traction appeared first on InvestorPlace.

Hold Asensus Surgical Stock as Next-Gen Senhance System Gains Traction

Asensus Surgical, Inc.'s (ASXC) CEO Anthony Fernando on Q1 2021 Results - Earnings Call Transcript

News for Asensus Surgical Stock (ASXC)